Rhabdomyosarcoma With FUS::TFCP2 Fusion in the Mandible: A Rare Aggressive Subtype, but Can Be Misdiagnosed as Ossifying Fibroma
International Journal of Surgical Pathology · 2024
DOI: 10.1177/10668969231189172 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Surgical Pathology, 2024. Verfasst von Peng Zhong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Daping Hospital, Amy Medical University (Third Military Medical University), Chongqing, China. Hauptthemen laut MEDLINE: Fibroma, Ossifying, Mandibular Neoplasms, Diagnostic Errors, Rhabdomyosarcoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Basic Research and Frontier exploration project of Chongqing Yuzhong District.
Abstract (Originalsprache)
Rhabdomyosarcoma (RMS) with TFCP2 rearrangement has been identified recently. This entity has a distinctive clinicopathologic features: a rapidly aggressive clinical course, a preference for the craniofacial bones, a spindle and epithelioid histomorphology, and positive immunohistochemistry for epithelial markers, ALK, and myogenic markers. RMS with TFCP2 rearrangement is rare and may be misdiagnosed as other spindle cell tumors. Here, we report a case of this entity arising in the mandible, which was initially diagnosed as ossifying fibroma in primary tumor in another hospital. A 26-year-old man presented with a recurred mass in the mandible for 1 month after the operation of mandibular tumor. The first excisional specimen was initially diagnosed as ossifying fibroma in another hospital. Histopathologic examination revealed the tumor with a hybrid spindle cell and epithelioid cytomorphology, spindle cells and spindle-to-epithelioid cells with eosinophilic and rich cytoplasm, with high-grade features, prominent nucleoli and some atypical mitosis. Immunohistochemical analysis revealed positivity for desmin, MYOD1, pan-keratin, ALK (5A4), ALK (D5F3). Based on the morphology and immunophenotype, molecular studies were performed, which revealed a FUS::TFCP2 fusion transcript, confirming the diagnosis of Rhabdomyosarcoma with FUS::TFCP2 fusion. Making a correct diagnosis is primarily dependent on awareness by the pathologist of this rare subtype of RMS and careful histopathological evaluation, supported by immunohistochemical and molecular analysis, to avoid potential diagnostic pitfalls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Daping Hospital, Amy Medical University (Third Military Medical University), Chongqing, China.
- Department of Pathology, Chongqing General Hospital, Chongqing, China.
ORCID-Profile: Ying Zeng
Förderung
- Basic Research and Frontier exploration project of Chongqing Yuzhong District
Zitieren
APA
Zhong, P., Wei, S., Xiao, H., & Zeng, Y. (2024). Rhabdomyosarcoma With FUS::TFCP2 Fusion in the Mandible: A Rare Aggressive Subtype, but Can Be Misdiagnosed as Ossifying Fibroma. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969231189172
Vancouver
Zhong P, Wei S, Xiao H, Zeng Y. Rhabdomyosarcoma With FUS::TFCP2 Fusion in the Mandible: A Rare Aggressive Subtype, but Can Be Misdiagnosed as Ossifying Fibroma. International Journal of Surgical Pathology. 2024. doi:10.1177/10668969231189172
BibTeX
@article{Zhong2024,
author = {Zhong, Peng and Wei, Shirong and Xiao, Hualiang and Zeng, Ying},
title = {Rhabdomyosarcoma With FUS::TFCP2 Fusion in the Mandible: A Rare Aggressive Subtype, but Can Be Misdiagnosed as Ossifying Fibroma},
journal = {International Journal of Surgical Pathology},
year = {2024},
doi = {10.1177/10668969231189172}
}
EUVIMED